These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9220119)

  • 21. Clozapine-induced tardive dyskinesia and hypothyroidism.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):245-6. PubMed ID: 16720805
    [No Abstract]   [Full Text] [Related]  

  • 22. Olanzapine for the treatment of tardive dyskinesia.
    Almeida OP
    J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267
    [No Abstract]   [Full Text] [Related]  

  • 23. Tardive Meige syndrome responsive to clozapine.
    Van Putten T; Wirshing WC; Marder SR
    J Clin Psychopharmacol; 1990 Oct; 10(5):381-2. PubMed ID: 1979568
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
    Duggal HS; Mendhekar DN
    Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
    [No Abstract]   [Full Text] [Related]  

  • 25. Worsening of tardive dyskinesia due to clozapine therapy.
    Raguraman J; Vijaysagar J
    J Postgrad Med; 2007; 53(3):218. PubMed ID: 17700005
    [No Abstract]   [Full Text] [Related]  

  • 26. Withdrawal dyskinesia after abrupt cessation of clozapine and benztropine.
    Songer DA; Schulte HM
    J Clin Psychiatry; 1996 Jan; 57(1):40. PubMed ID: 8543548
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M; Kumar A; Chopra K; Kulkarni SK
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
    Kantrowitz JT; Srihari VH; Tek C
    J Clin Psychopharmacol; 2007 Oct; 27(5):525-6. PubMed ID: 17873695
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.
    Alphs LD; Lee HS
    J Clin Psychiatry; 1991 Aug; 52(8):346-8. PubMed ID: 1869497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching between clozapine and risperidone treatment.
    Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol.
    Rosenheck R; Chang S; Choe Y; Cramer J; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 May; 61(5):382-6. PubMed ID: 10847315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia.
    Glazer WM; Hafez H
    Schizophr Res; 1990; 3(5-6):315-20. PubMed ID: 1980827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia associated with clozapine treatment.
    Bruscas MJ; Gonzalez F; Santos JL; Sánchez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):963-4. PubMed ID: 17331633
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 38. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.